---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-239454"
form_type: "8-K"
ticker: "AGIO"
cik: "0001439222"
company_name: "AGIOS PHARMACEUTICALS, INC."
filed_at: "2022-09-07T23:59:59+00:00"
generated_at: "2026-06-23T14:02:36.850121+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Agios Pharma CFO Jonathan Biller resigns effective Sept 16

## Summary
- Jonathan Biller notified resignation as CFO, head of corporate affairs, effective Sept 16, 2022.
- Resignation is to pursue other opportunities; no successor named as of filing date.
- Biller served as principal financial officer; departure creates CFO vacancy.

## SEC filing metadata
- accession: 0001193125-22-239454
- form_type: 8-K
- ticker: AGIO
- cik: 0001439222
- company_name: AGIOS PHARMACEUTICALS, INC.
- filed_at: 2022-09-07T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439222/000119312522239454/0001193125-22-239454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439222/000119312522239454/d388647d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-239454
- JSON: https://secwatch.observer/filing/0001193125-22-239454.json
- Plain text: https://secwatch.observer/filing/0001193125-22-239454.txt

## Key facts
- Executive change
  Jonathan Biller resigned as Chief Financial Officer at AGIOS PHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On September 6, 2022, Jonathan Biller notified the Company of his intention to resign as chief financial officer, head of corporate affairs and principal financial officer of the Company, effective September 16, 2022, in order to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439222/000119312522239454/0001193125-22-239454-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.